http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100651212-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B63-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4422 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-90 |
| filingDate | 2005-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2006-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100651212-B1 |
| titleOfInvention | Method for preparing amorphous lercanidipine |
| abstract | The present invention relates to a method for preparing amorphous lercanidipine, and more particularly, (1) dissolving lercanidipine in an organic solvent; (2) adding the solution to an organic solvent selected from cyclohexane, cyclopentane, hexane and petroleum ether to stir to form a precipitate; And (3) filtration, washing and vacuum drying the organic solvent used in step (2), wherein the method for preparing amorphous lercanidipine, according to the present invention, Properly adjusting the volume ratio provides the advantage of producing amorphous lercanidipine having excellent solubility and bioavailability in high purity and high yield.n n n n Lercanidipine, calcium antagonists, antihypertensive agents, angina |
| priorityDate | 2004-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.